S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.77 (-0.30%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.77 (-0.30%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.77 (-0.30%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)
S&P 500   5,091.44 (+0.09%)
DOW   39,159.98 (+0.23%)
QQQ   436.77 (-0.30%)
AAPL   182.54 (-0.99%)
MSFT   410.11 (-0.37%)
META   483.40 (-0.56%)
GOOGL   143.83 (-0.18%)
AMZN   174.24 (-0.19%)
TSLA   192.67 (-2.40%)
NVDA   790.50 (+0.65%)
NIO   5.46 (-6.67%)
AMD   176.17 (-3.13%)
BABA   75.98 (-0.18%)
T   16.83 (+1.45%)
F   12.15 (+0.25%)
MU   85.86 (-0.06%)
CGC   3.35 (-0.59%)
GE   153.17 (+0.99%)
DIS   107.70 (+0.06%)
AMC   4.48 (+1.36%)
PFE   27.82 (+0.98%)
PYPL   59.18 (+1.42%)
XOM   104.02 (-0.71%)

Aurinia Pharmaceuticals (AUPH) Short Interest Ratio & Short Volume

$6.00
0.00 (0.00%)
(As of 03:15 PM ET)

Aurinia Pharmaceuticals Short Interest Data

Current Short Volume
18,530,000 shares
Previous Short Volume
16,390,000 shares
Change Vs. Previous Month
+13.06%
Dollar Volume Sold Short
$139.72 million
Short Interest Ratio / Days to Cover
9.1
Last Record Date
January 31, 2024
Outstanding Shares
144,620,000 shares
Percentage of Shares Shorted
12.81%
Today's Trading Volume
1,976,051 shares
Average Trading Volume
2,865,863 shares
Today's Volume Vs. Average
69%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Aurinia Pharmaceuticals ?

Sign up to receive the latest short interest report for Aurinia Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AUPH Short Interest Over Time

AUPH Days to Cover Over Time

AUPH Percentage of Float Shorted Over Time


Aurinia Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/202418,530,000 shares $139.72 million +13.1%N/A9.1 $7.54
1/15/202416,390,000 shares $126.86 million +5.3%N/A7.9 $7.74
12/31/202315,570,000 shares $139.97 million -4.6%N/A7.8 $8.99
12/15/202316,320,000 shares $153.24 million -4.6%N/A8.2 $9.39
11/30/202317,110,000 shares $147.83 million -0.5%N/A8.9 $8.64
11/15/202317,190,000 shares $140.27 million -0.5%N/A9.2 $8.16
10/31/202317,280,000 shares $126.84 million -0.9%N/A10 $7.34
10/15/202317,430,000 shares $131.07 million +2.4%N/A8.4 $7.52
9/30/202317,030,000 shares $132.32 million +0.1%N/A8 $7.77
9/15/202317,010,000 shares $150.37 million +21.9%N/A7.8 $8.84
8/31/202313,960,000 shares $126.62 million -16.4%N/A6.5 $9.07
8/15/202316,700,000 shares $159.99 million +5.6%N/A7.2 $9.58
7/31/202315,820,000 shares $183.20 million -5.3%N/A6.5 $11.58
7/15/202316,710,000 shares $185.82 million +6.8%N/A6.9 $11.12
6/30/202315,650,000 shares $151.49 million -1.2%N/A6.2 $9.68
6/15/202315,840,000 shares $157.29 million -5.2%N/A5.9 $9.93
5/31/202316,700,000 shares $149.63 million +7.6%N/A5.7 $8.96
5/15/202315,520,000 shares $168.86 million -7.1%N/A5 $10.88
4/30/202316,710,000 shares $187.99 million -3.1%13.1%5.5 $11.25
4/15/202317,250,000 shares $193.55 million -0.2%13.5%5.9 $11.22
3/31/202317,280,000 shares $189.39 million +5.5%N/A5.6 $10.96
3/15/202316,380,000 shares $155.61 million +9.5%N/A5.1 $9.50
2/28/202314,960,000 shares $135.99 million +18.1%N/A5.1 $9.09
2/15/202312,670,000 shares $99.33 million +14.9%N/A4.6 $7.84
1/31/202311,030,000 shares $99.82 million +48.9%N/A3.8 $9.05
1/15/20237,410,000 shares $67.51 million -2.0%N/A2.3 $9.11
12/30/20227,560,000 shares $32.66 million -10.0%N/A2.5 $4.32
12/15/20228,400,000 shares $38.05 million -4.6%N/A3.5 $4.53
11/30/20228,800,000 shares $45.14 million +6.2%N/A3.5 $5.13
11/15/20228,290,000 shares $42.69 million -27.7%N/A3.3 $5.15
10/31/202211,460,000 shares $93.17 million -4.0%N/A4.9 $8.13
10/15/202211,940,000 shares $87.64 million -4.5%N/A4.9 $7.34
9/30/202212,500,000 shares $94 million +4.5%N/A5.4 $7.52
9/15/202211,960,000 shares $90.66 million -4.6%N/A4.4 $7.58
8/31/202212,530,000 shares $92.22 million -6.1%N/A4.5 $7.36
8/15/202213,340,000 shares $115.12 million -2.5%N/A4.9 $8.63
7/31/202213,680,000 shares $111.90 million -1.2%N/A4.7 $8.18
7/15/202213,840,000 shares $145.18 million -3.0%N/A5.5 $10.49
6/30/202214,260,000 shares $143.31 million +48.4%11.7%5.8 $10.05
6/15/20229,610,000 shares $95.24 million -6.5%7.9%4.2 $9.91













AUPH Short Interest - Frequently Asked Questions

What is Aurinia Pharmaceuticals' current short interest?

Short interest is the volume of Aurinia Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 18,530,000 shares of AUPH short. Learn More on Aurinia Pharmaceuticals' current short interest.

What is a good short interest ratio for Aurinia Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AUPH shares currently have a short interest ratio of 9.0. Learn More on Aurinia Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Aurinia Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aurinia Pharmaceuticals: GTS Securities LLC, Barclays PLC, Wolverine Trading LLC, Citadel Advisors LLC, Harvest Management LLC, PEAK6 Investments LLC, Concourse Financial Group Securities Inc., Simplex Trading LLC, and Cutler Group LLC CA. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Aurinia Pharmaceuticals' short interest increasing or decreasing?

Aurinia Pharmaceuticals saw a increase in short interest in January. As of January 31st, there was short interest totaling 18,530,000 shares, an increase of 13.1% from the previous total of 16,390,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Aurinia Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Aurinia Pharmaceuticals: ALX Oncology Holdings Inc. (13.21%), Tyra Biosciences, Inc. (10.81%), OPKO Health, Inc. (23.70%), Olema Pharmaceuticals, Inc. (12.18%), Verve Therapeutics, Inc. (21.94%), Lexicon Pharmaceuticals, Inc. (9.40%), Cryoport, Inc. (9.06%), CureVac (4.52%), ABIVAX Société Anonyme (0.17%), Evolus, Inc. (10.75%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.48 billion), General Motors ($3.85 billion), Charter Communications, Inc. ($3.38 billion), Occidental Petroleum Co. ($3.00 billion), Super Micro Computer, Inc. ($2.66 billion), Tractor Supply ($2.37 billion), Coinbase Global, Inc. ($2.25 billion), Moderna, Inc. ($2.11 billion), Royal Caribbean Cruises Ltd. ($2.06 billion), and Floor & Decor Holdings, Inc. ($1.67 billion). View all of the most shorted stocks.

What does it mean to sell short Aurinia Pharmaceuticals stock?

Short selling AUPH is an investing strategy that aims to generate trading profit from Aurinia Pharmaceuticals as its price is falling. AUPH shares are trading up $0.09 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aurinia Pharmaceuticals?

A short squeeze for Aurinia Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AUPH, which in turn drives the price of the stock up even further.

How often is Aurinia Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AUPH, twice per month. The most recent reporting period available is January, 31 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AUPH) was last updated on 2/23/2024 by MarketBeat.com Staff